Bread Financial Holdings, Inc. has priced a public offering of 4.8 million depositary shares representing interests in its Series B preferred stock, with an option for underwriters to buy an additional 720,000 shares. The offering is expected to raise approximately $115.3 million in net proceeds, which the company plans to use for general corporate purposes including potential loans to its subsidiary bank and share repurchases. The depositary shares will be listed on the New York Stock Exchange, and the offering is scheduled to close on May 12, 2026, subject to customary conditions. This move supports Bread Financial's financial flexibility and growth strategies.
Prestige Consumer Healthcare completed the acquisition of Australian therapeutic skin care company LaCorium Health for approximately $150 million in cash on July 1, 2026. LaCorium, known for brands like Dermal Therapy and Flexitol, generates about $4...
GuideAI Health Corp. has appointed Dr. James F. Benenati, a leading interventional radiologist, to its Advisory Board following FDA 510(k) clearance of its AI software, VascularAssist Occlusion Triage (VAOT). VAOT is designed to help radiologists pri...
Diginex Limited has agreed with Resulticks to extend the deadline for their acquisition deal to July 31, 2026, after securing firm funding intent from private investors. The company does not plan to seek public funding and expects this to be the fina...
Rogers Communications has agreed to buy the remaining 25% stake in Maple Leaf Sports & Entertainment (MLSE) from Kilmer Sports for C$4.35 billion, making Rogers the sole owner. This move aims to strengthen Rogers' position in Canadian sports and ente...
VERAXA Biotech updated on its progress in developing novel cancer therapies using its proprietary BiTAC platform, focusing on conditionally active T cell engagers and bispecific antibody-drug conjugates. The company plans to prioritize investment in ...
